Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 29, 2016
May 6, 2020
d14d1e42-3cce-41e9-863f-79be3022abbb
Related Documents
Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease
Guidance DocumentOctober 16, 2018Center for Drug Evaluation and Research
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product
Guidance DocumentApril 28, 2015Center for Drug Evaluation and Research
Quality Considerations in Demonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product Guidance for Industry
Guidance DocumentApril 30, 2015Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.